← Back to headlines
Abivax CEO Confident in June Trial Data for Better Deal Terms
Abivax CEO stated to CNBC that the company is not rushing for a deal, confident that key June trial data will enable them to secure better terms for potential partnerships, amidst analyst speculation of a takeover, reiterating no urgency for deal-making ahead of the readout.
24 Mar, 15:42 — 24 Mar, 17:04
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual139d ago
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
Read full article →seeking-alphaMixed138d ago
Abivax CEO suggests no urgency for deal-making ahead of key trial readout
Read full article →Coverage Timeline
First report: cnbc · 24 Mar, 15:42|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
